REYNO LEONARD 4
4 · C4 Therapeutics, Inc. · Filed Jul 12, 2023
Insider Transaction Report
Form 4
REYNO LEONARD
Chief Medical Officer
Transactions
- Award
Common Stock
2023-07-10+61,300→ 61,300 total - Award
Stock Option (Right to Buy)
2023-07-10+276,000→ 276,000 totalExercise: $3.50Exp: 2033-07-09→ Common Stock (276,000 underlying)
Footnotes (2)
- [F1]Represents restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. The RSUs shall vest in four equal annual installments following the grant date, with the first installment vesting on July 10, 2024, subject to the Reporting Person's continued service on each such vesting date.
- [F2]25% of the shares underlying this option shall vest and become exercisable on July 10, 2024, with the remainder vesting in twelve equal quarterly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.